台股 » 個股 » 智基 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智基

(6294)
可現股當沖
  • 股價
    101.0
  • 漲跌
    --
  • 漲幅
    0.00%
  • 成交量
    22
  • 產業
    上櫃 文化創意指數
  • 106人加入追蹤

    立即追蹤

  • 本地時間:14:30(已收盤)

     
智基 (6294)籌碼相關-元大-雙和 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元大-雙和 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/06/171101.0000.00101.0011460.68%
2024/06/141100.5000.00100.5011480.67%
2024/06/132100.2500.00100.5021521.31%
2024/06/121101.0000.00101.0011550.64%
2024/06/115101.9000.00101.5051563.20%
2024/06/071102.5000.00102.5011550.64%
2024/06/041102.0000.00103.0011580.63%
2024/05/301102.5000.00102.5011590.63%
2024/05/291102.5000.00102.5011590.63%
2024/05/281102.5000.00102.5011580.63%
2024/05/201103.5000.00103.5011540.65%
2024/05/171105.0000.00105.5011520.66%
2024/05/144101.7500.00102.0041442.77%
2024/05/1300.006.6107.00107.00-6.6127-5.19%
2024/04/2900.000118.00117.500116-0.02%
2024/04/160115.0000.00114.0001110.02%
2024/04/1200.000117.67118.000104-0.03%
2024/04/111119.501.3119.00119.50-0.3101-0.31%
2024/04/100.1127.001127.00127.00-0.995-0.94%
2024/04/091.7124.0000.00124.001.7772.14%
2024/04/080.1124.0000.00123.500.1730.14%
2024/04/0300.000123.00123.50071-0.04%
2024/04/0200.000122.50123.50070-0.03%
2024/04/012.1122.5400.00123.002.1692.94%
2024/03/222122.5000.00122.502603.32%
2024/03/182123.5000.00124.002513.91%
2024/02/2700.000.4112.50112.50-0.432-1.07%
2024/01/231111.0000.00111.001293.35%
2024/01/181111.0000.00111.001293.40%
2024/01/111111.0000.00111.501293.42%
2024/01/091112.0000.00112.501273.60%
2023/12/251115.0000.00114.501244.17%
2023/06/2800.001108.50108.00-147-2.11%
2023/06/2600.001108.50108.00-151-1.96%
2023/06/2100.001108.50108.00-152-1.91%
2023/06/2000.001108.50108.00-152-1.90%
2023/06/1600.002109.25109.50-254-3.64%
2023/06/1500.004108.75109.00-455-7.24%
2023/06/1300.001108.50108.00-154-1.83%
2023/06/1200.002107.75108.50-254-3.68%
2023/05/120.1107.0000.00106.500.1550.18%
2023/04/2000.000.2108.50109.00-0.253-0.28%
2023/04/100.2121.0000.00120.500.2390.38%
2023/02/020.5108.5000.00107.500.5391.27%
2022/12/1400.000.3103.07103.50-0.338-0.77%
2022/12/0800.001105.00105.00-138-2.60%
2022/12/0500.000103.00101.50032-0.06%
2022/12/010100.5000.00100.000290.07%
2022/11/301.1100.0900.00100.001.1273.81%
2022/11/290101.0000.00100.000270.06%
2022/11/180101.0000.00100.500220.09%
2022/11/170101.5000.00100.500220.13%
2022/11/160101.5000.00100.500210.20%
2022/11/090103.0000.00102.000190.13%
2022/11/04099.7000.0099.200190.10%
2022/11/030.1101.0000.00101.000.1190.42%
2022/09/1300.000.3109.00107.50-0.318-1.66%
2022/07/112100.0000.00100.502424.70%
2022/06/22298.5000.0098.002464.35%
2022/06/15299.6000.0099.502464.30%
2022/06/13199.7000.00100.001462.16%
2022/06/07199.6000.0099.501442.23%
2022/06/02199.6000.0099.601442.23%
2022/05/24198.0000.0098.101442.26%
2022/05/23298.1000.0098.502434.56%
2022/05/16199.2000.0098.701412.42%
2022/05/131102.5000.00102.501402.50%
2022/04/210124.0000.00124.000250.00%
2022/04/202124.0000.00124.502267.69%
2022/04/152126.5000.00124.502257.76%
2022/03/300136.0000.00136.000200.04%
2022/03/092124.0000.00125.502228.90%
2021/10/131125.0000.00125.001402.47%
2021/05/1200.001141.00142.00-144-2.23%
2021/05/0400.001142.00143.00-139-2.52%
2021/04/151147.0000.00146.501372.64%
2021/03/2600.001141.00141.00-127-3.62%
2021/03/241140.0000.00140.501273.64%
2021/03/2300.003142.00141.00-327-11.06%
2021/03/221139.5000.00140.501253.87%
2021/03/182135.0000.00135.002257.89%
2020/12/112125.5000.00124.502345.85%
2020/11/121119.0000.00119.001342.91%
2020/09/211110.5000.00110.501372.64%
2020/09/181110.5000.00110.501402.46%
2020/09/152111.2500.00111.502484.16%
2020/09/091110.5000.00111.001531.86%
2020/08/1700.001108.50107.50-156-1.79%
2020/07/061107.5000.00107.501631.59%
2020/06/2900.002107.50107.50-262-3.22%
2020/06/2400.001115.00116.00-159-1.67%
2020/06/183114.5000.00115.003545.53%
2020/05/2200.001110.00108.50-152-1.89%
2020/05/2100.002109.50110.00-252-3.79%
2020/05/143109.502108.50108.501492.00%
2020/05/132108.0000.00108.502484.16%
2020/05/1200.002108.50108.00-247-4.22%
2020/05/112106.0000.00106.002444.48%
2020/05/0800.001102.50102.50-142-2.33%
2020/05/0700.001101.50101.50-142-2.36%
2020/05/061101.5000.00102.001422.37%
2020/04/3000.002102.00102.00-241-4.83%
2020/04/292101.5000.00101.502424.66%
2020/04/2200.00199.5099.60-144-2.25%
2020/04/2100.001100.50100.00-143-2.28%
2020/04/2000.001100.50100.50-143-2.31%
2020/04/152100.5000.00101.002424.68%
2020/04/0900.003100.50100.00-342-7.00%
2020/04/07399.00298.1098.801422.33%
2020/04/06297.6000.0096.802424.69%
2020/03/30194.2000.0094.501412.39%
2020/03/26195.0000.0095.501402.44%
2020/03/18190.7000.0090.501362.78%
2020/02/1200.001101.00101.00-126-3.73%
2019/12/131102.5000.00102.001204.97%
2019/04/1900.001108.50107.50-138-2.57%
2019/04/1600.000.2109.50109.50-0.237-0.42%
2019/03/1400.005110.00110.00-525-19.62%
2019/03/1300.001109.50110.00-125-3.92%
2019/02/191108.5000.00108.501224.51%
2019/02/1800.0010107.70108.00-1021-45.52%
2019/01/3000.001107.00107.00-121-4.56%
2019/01/2300.001106.00106.00-123-4.19%
2018/10/041105.0000.00105.001452.21%
2018/10/032105.2500.00105.002454.37%
2018/09/282105.0000.00105.002474.24%
2018/09/1300.001106.00106.00-152-1.90%
2018/09/111104.5000.00105.001531.88%
2018/08/3000.002111.00111.00-254-3.70%
2018/08/161109.5000.00109.001611.64%
2018/08/0200.001112.00112.50-169-1.44%
2018/07/162124.5000.00125.502832.40%
2018/07/131124.5000.00124.501821.22%
2018/07/111124.0000.00124.001841.18%
2018/07/052123.5000.00123.502872.30%
2018/07/041121.0000.00122.001871.15%
2018/06/293123.1700.00123.503913.27%
2018/04/191122.5000.00123.0011620.62%
2018/03/3100.000129.50129.5001600.00%
2018/03/291129.0000.00128.5011610.62%
2018/03/2700.001129.50129.00-1163-0.61%
2018/03/212130.002128.00128.5001830.00%
2018/03/193128.001127.50127.5021761.13%
2018/03/0900.000.1120.00120.00-0.1172-0.06%
2018/02/1200.001114.50113.50-1167-0.60%
2018/02/0700.001116.00115.00-1165-0.60%
2018/01/2900.001121.50123.00-1162-0.62%
2018/01/221123.5000.00122.5011520.66%
2018/01/1900.002130.00124.00-2148-1.35%
2018/01/171121.0000.00121.5011290.77%
2018/01/0500.001111.50112.00-199-1.00%
慧智基因前列腺癌基因檢測套組 推行至國內千名患者Anue鉅亨-2021/09/14
疫情推升醫材需求強 雃博5月營收創同期高 慧智基因寫新猷Anue鉅亨-2021/06/10
智基 相關文章
智基 相關影音